BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

527 related articles for article (PubMed ID: 23225218)

  • 1. Monocyte/macrophage-elicited natural killer cell dysfunction in hepatocellular carcinoma is mediated by CD48/2B4 interactions.
    Wu Y; Kuang DM; Pan WD; Wan YL; Lao XM; Wang D; Li XF; Zheng L
    Hepatology; 2013 Mar; 57(3):1107-16. PubMed ID: 23225218
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human CD96 Correlates to Natural Killer Cell Exhaustion and Predicts the Prognosis of Human Hepatocellular Carcinoma.
    Sun H; Huang Q; Huang M; Wen H; Lin R; Zheng M; Qu K; Li K; Wei H; Xiao W; Sun R; Tian Z; Sun C
    Hepatology; 2019 Jul; 70(1):168-183. PubMed ID: 30411378
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Requirement of homotypic NK-cell interactions through 2B4(CD244)/CD48 in the generation of NK effector functions.
    Lee KM; Forman JP; McNerney ME; Stepp S; Kuppireddi S; Guzior D; Latchman YE; Sayegh MH; Yagita H; Park CK; Oh SB; Wülfing C; Schatzle J; Mathew PA; Sharpe AH; Kumar V
    Blood; 2006 Apr; 107(8):3181-8. PubMed ID: 15905190
    [TBL] [Abstract][Full Text] [Related]  

  • 4. XLP1 inhibitory effect by 2B4 does not affect DNAM-1 and NKG2D activating pathways in NK cells.
    Meazza R; Tuberosa C; Cetica V; Falco M; Loiacono F; Parolini S; Micalizzi C; Moretta A; Mingari MC; Moretta L; Bottino C; Aricò M; Pende D
    Eur J Immunol; 2014 May; 44(5):1526-34. PubMed ID: 24496997
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Unidirectional signaling triggered through 2B4 (CD244), not CD48, in murine NK cells.
    Kim EO; Kim N; Kim TJ; Kim K; Kim TW; Kumar V; Lee KM
    J Leukoc Biol; 2010 Oct; 88(4):707-14. PubMed ID: 20647560
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Homotypic cell to cell cross-talk among human natural killer cells reveals differential and overlapping roles of 2B4 and CD2.
    Kim EO; Kim TJ; Kim N; Kim ST; Kumar V; Lee KM
    J Biol Chem; 2010 Dec; 285(53):41755-64. PubMed ID: 20813844
    [TBL] [Abstract][Full Text] [Related]  

  • 7. NKG2D ligation relieves 2B4-mediated NK-cell self-tolerance in mice.
    Lee JE; Lim SA; Kim TJ; Kim K; Ng J; Kim YH; Jang IJ; Oh SB; Lee JC; Yee C; Kumar V; Lee KM
    Eur J Immunol; 2014 Jun; 44(6):1802-13. PubMed ID: 24610736
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The association of MHC class I proteins with the 2B4 receptor inhibits self-killing of human NK cells.
    Betser-Cohen G; Mizrahi S; Elboim M; Alsheich-Bartok O; Mandelboim O
    J Immunol; 2010 Mar; 184(6):2761-8. PubMed ID: 20164429
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Glycolytic activation of peritumoral monocytes fosters immune privilege via the PFKFB3-PD-L1 axis in human hepatocellular carcinoma.
    Chen DP; Ning WR; Jiang ZZ; Peng ZP; Zhu LY; Zhuang SM; Kuang DM; Zheng L; Wu Y
    J Hepatol; 2019 Aug; 71(2):333-343. PubMed ID: 31071366
    [TBL] [Abstract][Full Text] [Related]  

  • 10. hIL-15 gene-modified human natural killer cells (NKL-IL15) augments the anti-human hepatocellular carcinoma effect in vivo.
    Jiang W; Zhang C; Tian Z; Zhang J
    Immunobiology; 2014 Jul; 219(7):547-53. PubMed ID: 24721706
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CD48 stimulation by 2B4 (CD244)-expressing targets activates human NK cells.
    Messmer B; Eissmann P; Stark S; Watzl C
    J Immunol; 2006 Apr; 176(8):4646-50. PubMed ID: 16585556
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Subversion of natural killer cell responses by a cytomegalovirus-encoded soluble CD48 decoy receptor.
    Martínez-Vicente P; Farré D; Sánchez C; Alcamí A; Engel P; Angulo A
    PLoS Pathog; 2019 Apr; 15(4):e1007658. PubMed ID: 30947296
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mutational analysis of the human 2B4 (CD244)/CD48 interaction: Lys68 and Glu70 in the V domain of 2B4 are critical for CD48 binding and functional activation of NK cells.
    Mathew SO; Kumaresan PR; Lee JK; Huynh VT; Mathew PA
    J Immunol; 2005 Jul; 175(2):1005-13. PubMed ID: 16002700
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interleukin-17-educated monocytes suppress cytotoxic T-cell function through B7-H1 in hepatocellular carcinoma patients.
    Zhao Q; Xiao X; Wu Y; Wei Y; Zhu LY; Zhou J; Kuang DM
    Eur J Immunol; 2011 Aug; 41(8):2314-22. PubMed ID: 21674477
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 2B4 inhibits the apoptosis of natural killer cells through phosphorylated extracellular signal-related kinase/B-cell lymphoma 2 signal pathway.
    Mou J; Xie L; Xu Y; Zhou T; Liu Y; Huang Q; Tang K; Tian Z; Xing H; Qiu S; Rao Q; Wang M; Wang J
    Cytotherapy; 2023 Oct; 25(10):1080-1090. PubMed ID: 37516949
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Distinctive lack of CD48 expression in subsets of human dendritic cells tunes NK cell activation.
    Morandi B; Costa R; Falco M; Parolini S; De Maria A; Ratto G; Mingari MC; Melioli G; Moretta A; Ferlazzo G
    J Immunol; 2005 Sep; 175(6):3690-7. PubMed ID: 16148114
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reciprocal regulation of human natural killer cells and macrophages associated with distinct immune synapses.
    Nedvetzki S; Sowinski S; Eagle RA; Harris J; Vély F; Pende D; Trowsdale J; Vivier E; Gordon S; Davis DM
    Blood; 2007 May; 109(9):3776-85. PubMed ID: 17218381
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cutting edge: the NK cell receptor 2B4 augments antigen-specific T cell cytotoxicity through CD48 ligation on neighboring T cells.
    Lee KM; Bhawan S; Majima T; Wei H; Nishimura MI; Yagita H; Kumar V
    J Immunol; 2003 May; 170(10):4881-5. PubMed ID: 12734329
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 2B4 acts as a non-major histocompatibility complex binding inhibitory receptor on mouse natural killer cells.
    Lee KM; McNerney ME; Stepp SE; Mathew PA; Schatzle JD; Bennett M; Kumar V
    J Exp Med; 2004 May; 199(9):1245-54. PubMed ID: 15123744
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 2B4-mediated activation of human natural killer cells.
    Tangye SG; Cherwinski H; Lanier LL; Phillips JH
    Mol Immunol; 2000 Jun; 37(9):493-501. PubMed ID: 11163399
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.